ClinicalTrials.Veeva

Menu

Is Eovist Suitable for Arterial-Phase MR Imaging of Liver

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Liver Disease

Treatments

Procedure: Non Eovist Contrast
Procedure: Eovist Contrast

Study type

Interventional

Funder types

Other

Identifiers

NCT02684526
HUM00038856

Details and patient eligibility

About

To examine the quality of liver images produced when the contrast agent Eovist is used during MRI.

Full description

Researchers will review data from the Eovist MRI and compare the scan with previous MRI exams the patient had with the same or other contrast agents.

To determine the efficacy of Eovist contrast agent in producing MRI images of the liver. We will monitor patients for any unusual symptoms (adverse events) when the contrast is given.

Patients are asked to hold their breath during an MRI scan. Eovist may interfere with the "breath hold" which could result in more breathing artifacts (based on a qualitative scale) on arterial images when the patients are given Eovist vs. other contrast agents.

Enrollment

198 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. You have had a scheduled MRI(magnetic resonance imaging) scan using the contrast agent EOVIST.
  2. Male and females 21 years of age or older.

Exclusion criteria

  1. Does not have a contraindication for MRI (e.g. cardiac pacemaker, ferromagnetic or metallic implants).
  2. Pregnancy

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

198 participants in 2 patient groups

Eovist Contrast agent
Active Comparator group
Description:
To determine if Eovist contrast agent induces a transient abnormal sensation at first pass, which prevents patients from holding their breath at end of arterial phase liver MRI scans.
Treatment:
Procedure: Eovist Contrast
Non Eovist Contrast agents
Active Comparator group
Description:
To determine if using non-Eovist contrast agents produce the same abnormal sensation at first pass, which prevents patients from holding their breath at end of arterial phase liver MRI scans. Determine if this event is exclusive to Eovist contrast.
Treatment:
Procedure: Non Eovist Contrast

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems